FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891302013> ?p ?o ?g. }

• W2891302013 abstract "Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. It is increasingly recognized that the phenotype of NASH may involve a number of different pathways, of which each could become important therapeutic targets. The aim of this study is to use high resolution mass spectrometry (MS) and phosphoproteomics techniques to assess the serum proteome and hepatic phosphoproteome in subjects with NASH-related fibrosis. Sixty-seven biopsy-proven NAFLD subjects with frozen sera and liver tissue were included. Reverse phase protein microarray was used to quantify the phosphorylation of key signaling proteins in liver and nano-liquid chromatography (LC)-MS was used to sequence target biomarkers in the serum. An image analysis algorithm was used to quantify the percentage of collagen (% collagen) using computer-assisted morphometry. Using multiple regression models, serum proteomes and phosphorylated hepatic proteins that were independently (p ≤ 0.05) associated with advanced fibrosis (stage ≥ 2) and higher % collagen were assessed. Phosphorylated signaling pathways in the liver revealed that apoptosis signal-regulating kinase 1, mitogen-activated protein kinase (ASK1-MAPK pathway involving ASK1 S38 (p < 0.02) and p38 MAPK (p = 0.0002)) activated by the inflammatory cytokine interleukin (IL-10) (p < 0.001), were independently associated with higher % collagen. LC-MS data revealed that serum alpha-2 macroglobulin (α2M) (p = 0.0004) and coagulation factor V (p = 0.0127) were independently associated with higher % hepatic collagen. Simultaneous profiling of serum proteome and hepatic phosphoproteome reveals that the activation of ASK1 S38, p38 MAPK in the liver, and serum α2M and coagulation factor V are independently associated with hepatic collagen deposition in patients with NASH. These data suggest the role of these pathways in the pathogenesis of NASH-related fibrosis as a potential therapeutic target." @default.
• W2891302013 created "2018-09-27" @default.
• W2891302013 creator A5000030596 @default.
• W2891302013 creator A5013069852 @default.
• W2891302013 creator A5017966515 @default.
• W2891302013 creator A5019796339 @default.
• W2891302013 creator A5020791562 @default.
• W2891302013 creator A5022227592 @default.
• W2891302013 creator A5023762376 @default.
• W2891302013 creator A5024470010 @default.
• W2891302013 creator A5047966530 @default.
• W2891302013 creator A5050976117 @default.
• W2891302013 creator A5054632221 @default.
• W2891302013 creator A5065504305 @default.
• W2891302013 creator A5066679592 @default.
• W2891302013 creator A5073337554 @default.
• W2891302013 creator A5074202766 @default.
• W2891302013 creator A5077153492 @default.
• W2891302013 creator A5080386622 @default.
• W2891302013 date "2018-09-12" @default.
• W2891302013 modified "2023-10-16" @default.
• W2891302013 title "An exploratory study examining how nano-liquid chromatography–mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease" @default.
• W2891302013 cites W1499223853 @default.
• W2891302013 cites W1856581299 @default.
• W2891302013 cites W1861665996 @default.
• W2891302013 cites W1867010939 @default.
• W2891302013 cites W1963683487 @default.
• W2891302013 cites W1965002909 @default.
• W2891302013 cites W1966724121 @default.
• W2891302013 cites W1967932879 @default.
• W2891302013 cites W1973939264 @default.
• W2891302013 cites W1974436444 @default.
• W2891302013 cites W1979240594 @default.
• W2891302013 cites W1983417944 @default.
• W2891302013 cites W1995620440 @default.
• W2891302013 cites W1996415443 @default.
• W2891302013 cites W2004338566 @default.
• W2891302013 cites W2025512398 @default.
• W2891302013 cites W2027557878 @default.
• W2891302013 cites W2035378093 @default.
• W2891302013 cites W2044136233 @default.
• W2891302013 cites W2045911846 @default.
• W2891302013 cites W2046626713 @default.
• W2891302013 cites W2048895915 @default.
• W2891302013 cites W2049138891 @default.
• W2891302013 cites W2055975580 @default.
• W2891302013 cites W2056850496 @default.
• W2891302013 cites W2063437798 @default.
• W2891302013 cites W2066243203 @default.
• W2891302013 cites W2071841244 @default.
• W2891302013 cites W2075754351 @default.
• W2891302013 cites W2080050561 @default.
• W2891302013 cites W2080501134 @default.
• W2891302013 cites W2102603833 @default.
• W2891302013 cites W2105359426 @default.
• W2891302013 cites W2112496618 @default.
• W2891302013 cites W2115162045 @default.
• W2891302013 cites W2117546887 @default.
• W2891302013 cites W2118593202 @default.
• W2891302013 cites W2120018526 @default.
• W2891302013 cites W2120247510 @default.
• W2891302013 cites W2121048362 @default.
• W2891302013 cites W2129275826 @default.
• W2891302013 cites W2140092994 @default.
• W2891302013 cites W2155443732 @default.
• W2891302013 cites W2155503613 @default.
• W2891302013 cites W2157636987 @default.
• W2891302013 cites W2162739621 @default.
• W2891302013 cites W2166261061 @default.
• W2891302013 cites W2186224094 @default.
• W2891302013 cites W2204688218 @default.
• W2891302013 cites W2252972718 @default.
• W2891302013 cites W2415215726 @default.
• W2891302013 cites W2508708811 @default.
• W2891302013 cites W2528921242 @default.
• W2891302013 cites W2580009538 @default.
• W2891302013 cites W2790625788 @default.
• W2891302013 cites W4232218865 @default.
• W2891302013 cites W4237585456 @default.
• W2891302013 cites W982485615 @default.
• W2891302013 doi "https://doi.org/10.1186/s12916-018-1136-1" @default.
• W2891302013 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6134795" @default.
• W2891302013 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30205811" @default.
• W2891302013 hasPublicationYear "2018" @default.
• W2891302013 type Work @default.
• W2891302013 sameAs 2891302013 @default.
• W2891302013 citedByCount "7" @default.
• W2891302013 countsByYear W28913020132019 @default.
• W2891302013 countsByYear W28913020132020 @default.
• W2891302013 countsByYear W28913020132021 @default.
• W2891302013 countsByYear W28913020132022 @default.
• W2891302013 crossrefType "journal-article" @default.
• W2891302013 hasAuthorship W2891302013A5000030596 @default.
• W2891302013 hasAuthorship W2891302013A5013069852 @default.
• W2891302013 hasAuthorship W2891302013A5017966515 @default.
• W2891302013 hasAuthorship W2891302013A5019796339 @default.
• W2891302013 hasAuthorship W2891302013A5020791562 @default.
• W2891302013 hasAuthorship W2891302013A5022227592 @default.
• W2891302013 hasAuthorship W2891302013A5023762376 @default.
• W2891302013 hasAuthorship W2891302013A5024470010 @default.

• next